nach oben

Reactions Weekly

Erschienen in:

01.03.2017 | Case report

Azathioprine

Leucopenia, raised transaminase levels and nausea: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

…

The patients were scheduled to receive azathioprine at 25 or 50 mg daily and was to be increased 2 weeks later to 2 mg/kg based on body weight. The dose on which the ADR developed was unknown

Chen H, et al. Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder. European Journal of Neurology 24: 219-226, No. 1, Jan 2017. Available from: URL: http://doi.org/10.1111/ene.13186 - ChinaCrossRefPubMed

Titel: Azathioprine
Leucopenia, raised transaminase levels and nausea: 2 case reports
Publikationsdatum: 01.03.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-27823-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Azathioprine

Leucopenia, raised transaminase levels and nausea: 2 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Multiple drugs

Sebelipase alfa

Bupivacaine

Antiparkinsonians/GABA-A-receptor-agonists

Fentanyl/midazolam/propofol

Nivolumab